Established in 2012, Accretion Pharmaceuticals Limited is a Gujarat-based pharmaceutical company engaged in manufacturing and marketing a diverse range of healthcare products, including tablets, capsules, oral liquids, external preparations (ointments, creams, gels, lotions, medicated shampoos, mouthwashes, and dusting powders), and oral powders (sachets and dry syrups).
The company also provides contract manufacturing services from its ISO-certified (9001:2015, 14001:2015, and 22000:2005) facility in Ahmedabad, Sanand, demonstrating its commitment to quality and environmental standards. With a growing global presence, the company exports to over 20 countries across Africa, Southeast Asia, and the Middle East.
Accretion Pharmaceuticals boasts a robust product portfolio, covering antibiotics, anti-inflammatory drugs, pain management solutions, cardiovascular and gastrointestinal medicines, pediatric syrups, respiratory treatments, dermatological products, and Ayurvedic/herbal wellness solutions. As of January 2025, the company employs 83 professionals, including four Executive Directors.
The company’s IPO will open for subscription from May 14 to May 16, 2025, with a price band of ₹96 to ₹101 per share. The allocation is divided into 35% for retail investors, 50% for QIBs, and 15% for HNIs. The share allotment will be finalized on May 19, 2025, and the stock is set to list on the NSE on May 21, 2025. Financially, the company has shown strong growth, with revenue increasing to ₹33.94 crores in 2024 from ₹29.53 crores in 2023, while profits surged significantly to ₹3.88 crores from just ₹0.10 crores in the same period.
Accretion Pharmaceuticals IPO Details
| IPO Date | May 14, 2025 to May 16, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price | ₹96 to ₹101 per share |
| Lot Size | 1,200 Shares |
| Total Issue Size | Approx ₹29.75 Crores |
| Fresh Issue | Approx ₹29.75 Crores |
| Issue Type | Book Built IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 81,70,000 shares |
| Share Holding Post Issue | 1,11,16,000 shares |
Accretion Pharmaceuticals IPO Dates
The initial public offering (IPO) of Accretion Pharmaceuticals will be available for subscription from May 14, 2025 to May 16, 2025.
| IPO Open Date | Wed, May 14, 2025 |
| IPO Close Date | Fri, May 16, 2025 |
| Tentative Allotment | Mon, May 19, 2025 |
| Refunds | Tue, May 20, 2025 |
| Credit of Shares to Demat | Tue, May 20, 2025 |
| IPO Listing Date | Wed, May 21, 2025 |
| UPI Mandate Confirmation Deadline | 5 PM on May 16, 2025 |
Accretion Pharmaceuticals IPO Market Lot
The minimum investment for Accretion Pharmaceuticals IPO is ₹121,200, equivalent to 1,200 shares per market lot.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 1200 | ₹1,21,200 |
| Retail Maximum | 1 | 1200 | ₹1,21,200 |
| S-HNI Minimum | 2 | 2,400 | ₹2,42,400 |
